Pfizer, Triana Launch Up-to-$1.5B+ Molecular Glue Collaboration
Pfizer will apply Triana Biomedicines’ target-first and proximity-first discovery platform to discover molecular glue degraders for unspecified “multiple” targets in oncology and several other disease areas, t…
Read guide →